Mentioned : Amgen Inc (AMGN), Eli Lilly and Co (LLY), Novo Nordisk AS ADR (NVO), Pfizer Inc (PFE), Roche Holding AG Ordinary Shares new (ROP) Pharmaceutical investing has seen huge moves in the industrys stocks over the past year, with one area grabbing particular attention: obesity drugs
DL declares receipt of grants from Abbvie, Amgen, AstraZeneca, Bristol-Myers Squibb, Pfizer and Sanofi, and past participation in advisory boards and/or receipt of honoraria from Abbvie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Edwards Lifesciences, Novartis, Pfizer, Sanofi and Shire, outside the submitted work
10.1016/S0006-8993(98)00130-9 200 MoghaddamB.BolinaoM
Harvey KF, Zhang X, Thomas DM
But with with its amazing benefits come some potential concerns around its safety and potential side effects